Company intelligence / Profile preview

Goodmed

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

GoodMed Healthcare UK focuses on manufacturing international quality standard pharmaceutical medicines at affordable cost, with technical collaborations in Kenya. Their products are approved by stringent regulatory authorities. No clinical trial results are disclosed; the business model centers on commercial distribution rather than novel drug development.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Technical collaboration with local players in KenyaMajor supplier: Prism Bio Pharma Pvt Ltd (India)

Beyond the preview

Go deeper on Goodmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goodmed.

Explore the full profile